Ligand validation:8FIK

IHP: INOSITOL HEXAKISPHOSPHATE

IHP is a Ligand Of Interest in 8FIK designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
8FIK_IHP_A_204	17%	52%	0.274	0.85	0.86	0.98	-	3	0	0	100%	1
8FIM_IHP_B_201	36%	60%	0.167	0.861	0.74	0.77	-	1	1	0	100%	1
8FIL_IHP_B_201	28%	52%	0.21	0.861	0.82	1.04	-	2	0	0	100%	1
1ZY7_IHP_A_901	99%	48%	0.055	0.989	0.99	1.03	2	2	0	0	100%	1
3HO6_IHP_A_270	97%	29%	0.072	0.985	2.06	0.91	15	2	0	0	100%	1
4LV7_IHP_A_501	92%	41%	0.093	0.986	1.11	1.25	1	6	0	0	100%	1
3EEB_IHP_B_210	92%	52%	0.091	0.983	0.86	1.01	-	-	0	0	100%	1
3PEE_IHP_B_256	91%	49%	0.099	0.988	0.87	1.1	-	3	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.